Investor mix
7 investors on record; lead investors include S3 Ventures, Baxter.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Other / undisclosed | 3 | 43% |
Minimally invasive therapies for renal disease
7 investors on record; lead investors include S3 Ventures, Baxter.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Other / undisclosed | 3 | 43% |